| Record ID | harvard_bibliographic_metadata/ab.bib.11.20150123.full.mrc:438141321:1088 |
| Source | harvard_bibliographic_metadata |
| Download Link | /show-records/harvard_bibliographic_metadata/ab.bib.11.20150123.full.mrc:438141321:1088?format=raw |
LEADER: 01088nam a22003254a 4500
001 011490151-1
005 20080616170347.0
008 061214s2008 gw a b 001 0 eng
010 $a 2007920488
016 7 $a101320586$2DNLM
020 $a9783540331766 (alk. paper)
020 $a354033176X (alk. paper)
035 0 $aocn190867190
040 $aNLM$cNLM$dBTCTA$dBAKER$dYDXCP$dOHX
042 $apcc
050 00 $aRC271.N46$bT86 2008
060 00 $a2007 L-275
060 10 $aQZ 267$bT925 2008
245 00 $aTumor angiogenesis :$bbasic mechanisms and cancer therapy /$cDieter Marmé, Norbert Fusenig, (editors).
260 $aBerlin ;$aNew York :$bSpringer,$cc2008.
300 $axviii, 845 p. :$bill. (some col.) ;$c25 cm.
504 $aIncludes bibliographical references and index.
650 12 $aNeoplasms$xdrug therapy.
650 22 $aAngiogenesis Inhibitors$xtherapeutic use.
650 22 $aNeoplasms$xblood supply.
650 22 $aNeovascularization, Pathologic$xdrug therapy.
700 1 $aMarmé, D.$q(Dieter)
700 1 $aFusenig, N. E.
988 $a20080613
906 $0OCLC